HEXPOL (HPOL) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
23 Oct, 2026Executive summary
Q3 sales rose 13% YoY to SEK 5.3 billion, including 12% organic growth and 1% positive FX; all three business areas and regions grew.
Adjusted EBIT increased 5% to SEK 723 million, while adjusted margin declined 110 bps to 13.6%; growth reflected higher volumes and prices, with overhead costs weighing on margins.
Financial highlights
Q3 reported EBIT was SEK 651 million versus SEK 688 million; adjusted EBIT was SEK 723 million versus SEK 688 million. Adjusted profit after tax was SEK 502 million and adjusted EPS SEK 1.46.
Jan–Sep sales increased 2% to SEK 15,348 million; adjusted EBIT declined 4% to SEK 2,196 million, with adjusted margin at 14.3% versus 15.1%.
Q3 adjusted EBIT drivers included +SEK 129 million from sales, -SEK 17 million from gross margin and -SEK 77 million from OpEx; gross margin was similar to last year.
Outlook and guidance
Priorities include converting growth into higher margins, product development and production automation through Mixing 5.0; no specific Thermoplastic Compounding growth outlook was given.
Raw material prices remain volatile; price adjustments have compensated for rising costs, and Symplast closing was expected in Q1 2027, subject to customary conditions.
Latest events from HEXPOL
- Q2 2026 saw 8% organic sales growth, resilient margins, and strong cash flow despite market volatility.HPOL
Q2 2026 - Higher volumes but lower sales and EBIT; cash flow up, focus on growth and M&A.HPOL
Q1 2026 - Q4 saw lower sales and margins from FX and mix, but volumes and cash flow improved.HPOL
Q4 2025 - 2030 targets: >10% EPS CAGR, 14-16% EBIT margin, and accelerated M&A in Thermoplastics.HPOL
CMD 2025 - Sales down 6%, EBIT margin at 14.7%, strong cash flow, acquisitions offset weak North America.HPOL
Q3 2025 - Sales and profit declined 9% year-over-year, but margins and cash flow stayed strong.HPOL
Q3 2024 - Sales fell but margins rose, supporting a strong outlook and continued M&A focus.HPOL
Q2 2024 - Sales up 1% and Engineered Products grew 15%, but margins pressured by product mix.HPOL
Q1 2025 - Sales and profit declined, but cash flow and margins remained strong amid efficiency actions.HPOL
Q4 2024